Wiezorek Jeffrey

Avg. Two Year Performance

No purchase track record
(23%) Avg. Sale Return
(11%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(1%)(5%)(17%)2%(23%)
Sale Success Rate8 of 2210 of 2210 of 228 of 220 of 22
Drugs » Biotechnology

SVP Clinical Development:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--